Genetics of Dupuytren's disease

Joint Bone Spine

Volumn 79, Issue 1, 2012, Pages 7-12

  Michou, Laëtitia ^a   Lermusiaux, Jean Luc ^b   Teyssedou, Jean Pierre ^b   Bardin, Thomas ^b   Beaudreuil, Johann ^b   Petit Teixeira, Elisabeth ^c  

^a LAVAL UNIVERSITY   (Canada)

^b CENTRE VIGGO PETERSEN   (France)

^c University of Evry Val d'Essonne   (France)

Author keywords

catenin; Dupuytren's disease; Gene expression; Heritability; TGF

Indexed keywords

BETA CATENIN; COLLAGEN; HLA DRB1 ANTIGEN; RIBOSOME RNA; TRANSFORMING GROWTH FACTOR BETA;

ALCOHOL CONSUMPTION; ALLELE; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; CAUCASIAN; CHROMOSOME 10Q; CHROMOSOME 16P; CHROMOSOME 16Q; CHROMOSOME 17P; CONNECTIVE TISSUE DISEASE; COPY NUMBER VARIATION; DIABETES MELLITUS; DISEASE ASSOCIATION; DUPC1 GENE; DUPUYTREN CONTRACTURE; ENVIRONMENTAL FACTOR; EPILEPSY; EXTRACELLULAR MATRIX; GENE; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; MANUAL LABOR; MYOFIBROBLAST; PALMAR FASCIA; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; SHORT SURVEY; TOBACCO;

BETA CATENIN; CHROMOSOME ABERRATIONS; COMORBIDITY; DIABETES MELLITUS; DNA, MITOCHONDRIAL; DUPUYTREN CONTRACTURE; EPILEPSY; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MITOCHONDRIA;

EID: 84855641371     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2011.05.027     Document Type: Short Survey

References (47)

1. Shih B., Bayat A. Scientific understanding and clinical management of Dupuytren disease. Nat Rev Rheumatol 2010, 6:715-726.
2. Hueston J. Dupuytren's contracture 1963, E&S Livingstone, Edinburgh, p. 51-120.
3. Hindocha S., Stanley J.K., Watson S., et al. Dupuytren's diathesis revisited: evaluation of prognostic indicators for risk of disease recurrence. J Hand Surg Am 2006, 31:1626-1634.
4. Shaw R.B., Chong A.K., Zhang A., et al. Dupuytren's disease: history, diagnosis, and treatment. Plast Reconstr Surg 2007, 120:44e-54e.
5. Hindocha S., McGrouther D.A., Bayat A. Epidemiological evaluation of Dupuytren's disease incidence and prevalence rates in relation to etiology. Hand (N. Y.) 2009, 4:256-269.
6. McFarlane R.M. On the origin and spread of Dupuytren's disease. J Hand Surg Am 2002, 27:385-390.
7. Slattery D. Review: Dupuytren's disease in Asia and the migration theory of Dupuytren's disease. ANZ J Surg 2010, 80:495-499.
8. Degreef I., Steeno P., De Smet L. A survey of clinical manifestations and risk factors in women with Dupuytren's disease. Acta Orthop Belg 2008, 74:456-460.
9. Burke F.D., Proud G., Lawson I.J., et al. An assessment of the effects of exposure to vibration, smoking, alcohol and diabetes on the prevalence of Dupuytren's disease in 97,537miners. J Hand Surg Eur Vol 2007, 32:400-406.
10. Logan A.J., Mason G., Dias J., et al. Can rock climbing lead to Dupuytren's disease?. Br J Sports Med 2005, 39:639-644.
11. Geoghegan J.M., Forbes J., Clark D.I., et al. Dupuytren's disease risk factors. J Hand Surg Br 2004, 29:423-426.
12. Hindocha S., John S., Stanley J.K., et al. The heritability of Dupuytren's disease: familial aggregation and its clinical significance. J Hand Surg Am 2006, 31:204-210.
13. Lyall H.A. Dupuytren's disease in identical twins. J Hand Surg Br 1993, 18:368-370.
14. Nyberg L.M., Bias W.B., Hochberg M.C., et al. Identification of an inherited form of Peyronie's disease with autosomal dominant inheritance and association with Dupuytren's contracture and histocompatibility B7 cross-reacting antigens. J Urol 1982, 128:48-51.
15. Bias W.B., Nyberg L.M., Hochberg M.C., et al. Peyronie's disease: a newly recognized autosomal-dominant trait. Am J Med Genet 1982, 12:227-235.
16. Dal Cin P., De Smet L., Sciot R., et al. Trisomy 7 and trisomy 8 in dividing and non-dividing tumor cells in Dupuytren's disease. Cancer Genet Cytogenet 1999, 108:137-140.
17. Casalone R., Mazzola D., Meroni E., et al. Cytogenetic and interphase cytogenetic analyses reveal chromosome instability but no clonal trisomy 8 in Dupuytren contracture. Cancer Genet Cytogenet 1997, 99:73-76.
18. Kaur S., Forsman M., Ryhanen J., et al. No gene copy number changes in Dupuytren's contracture by array comparative genomic hybridization. Cancer Genet Cytogenet 2008, 183:6-8.
19. Shih B.B., Tassabehji M., Watson J.S., et al. Genome-wide high-resolution screening in Dupuytren's disease reveals common regions of DNA copy number alterations. J Hand Surg Am 2010, 35:1172-1183.
20. Bache I., Nielsen N.M., Rostgaard K., et al. Autoimmune diseases in a Danish cohort of 4866carriers of constitutional structural chromosomal rearrangements. Arthritis Rheum 2007, 56:2402-2409.
21. Hu F.Z., Nystrom A., Ahmed A., et al. Mapping of an autosomal dominant gene for Dupuytren's contracture to chromosome 16q in a Swedish family. Clin Genet 2005, 68:424-429.
22. Bayat A., Watson J.S., Stanley J.K., et al. Genetic susceptibility in Dupuytren's disease. TGF-beta1 polymorphisms and Dupuytren's disease. J Bone Joint Surg Br 2002, 84:211-215.
23. Bayat A., Alansar A., Hajeer A.H., et al. Genetic susceptibility in Dupuytren's disease: lack of association of a novel transforming growth factor beta(2) polymorphism in Dupuytren's disease. J Hand Surg Br 2002, 27:47-49.
24. Bayat A., Stanley J.K., Watson J.S., et al. Genetic susceptibility to Dupuytren's disease: transforming growth factor beta receptor (TGFbetaR) gene polymorphisms and Dupuytren's disease. Br J Plast Surg 2003, 56:328-333.
25. Bayat A., Watson J.S., Stanley J.K., et al. Genetic susceptibility to dupuytren disease: association of Zf9 transcription factor gene. Plast Reconstr Surg 2003, 111:2133-2139.
26. Brown J.J., Ollier W., Thomson W., et al. Positive association of HLA-DRB1*15 with Dupuytren's disease in Caucasians. Tissue Antigens 2008, 72:166-170.
27. Bayat A., Walter J., Lambe H., et al. Identification of a novel mitochondrial mutation in Dupuytren's disease using multiplex DHPLC. Plast Reconstr Surg 2005, 115:134-141.
28. Ojwang J.O., Adrianto I., Gray-McGuire C., et al. Genome-Wide Association Scan of Dupuytren's Disease. J Hand Surg Am 2010, 35:2039-2045.
29. Al-Qattan M.M. Factors in the pathogenesis of Dupuytren's contracture. J Hand Surg Am 2006, 31:1527-1534.
30. Bisson M.A., Beckett K.S., McGrouther D.A., et al. Transforming growth factor-beta1 stimulation enhances Dupuytren's fibroblast contraction in response to uniaxial mechanical load within a 3-dimensional collagen gel. J Hand Surg Am 2009, 34:1102-1110.
31. Vi L., Feng L., Zhu R.D., et al. Periostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren's disease and adjacent palmar fascia cells. Exp Cell Res 2009, 315:3574-3586.
32. Pagnotta A., Specchia N., Greco F. Androgen receptors in Dupuytren's contracture. J Orthop Res 2002, 20:163-168.
33. Zhang A.Y., Fong K.D., Pham H., et al. Gene expression analysis of Dupuytren's disease: the role of TGF-beta2. J Hand Surg Eur Vol 2008, 33:783-790.
34. Johnston P., Chojnowski A.J., Davidson R.K., et al. A complete expression profile of matrix-degrading metalloproteinases in Dupuytren's disease. J Hand Surg Am 2007, 32:343-351.
35. Ulrich D., Ulrich F., Piatkowski A., et al. Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease. Arch Orthop Trauma Surg 2009, 129:1453-1459.
36. Johnston P., Larson D., Clark I.M., et al. Metalloproteinase gene expression correlates with clinical outcome in Dupuytren's disease. J Hand Surg Am 2008, 33:1160-1167.
37. Qian A., Meals R.A., Rajfer J., et al. Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture. Urology 2004, 64:399-404.
38. Pan D., Watson H.K., Swigart C., et al. Microarray gene analysis and expression profiles of Dupuytren's contracture. Ann Plast Surg 2003, 50:618-622.
39. Lee L.C., Zhang A.Y., Chong A.K., et al. Expression of a novel gene, MafB, in Dupuytren's disease. J Hand Surg Am 2006, 31:211-218.
40. Satish L., Laframboise W.A., O'Gorman D.B., et al. Identification of differentially expressed genes in fibroblasts derived from patients with Dupuytren's Contracture. BMC Med Genomics 2008, 1:10.
41. Rehman S., Salway F., Stanley J.K., et al. Molecular phenotypic descriptors of Dupuytren's disease defined using informatics analysis of the transcriptome. J Hand Surg Am 2008, 33:359-372.
42. Shih B., Wijeratne D., Armstrong D.J., et al. Identification of biomarkers in Dupuytren's disease by comparative analysis of fibroblasts versus tissue biopsies in disease-specific phenotypes. J Hand Surg Am 2009, 34:124-136.
43. Mosakhani N., Guled M., Lahti L., et al. Unique microRNA profile in Dupuytren's contracture supports deregulation of beta-catenin pathway. Mod Pathol 2010, 23:1544-1552.
44. Kraljevic Pavelic S., Sedic M., Hock K., et al. An integrated proteomics approach for studying the molecular pathogenesis of Dupuytren's disease. J Pathol 2009, 217:524-533.
45. Shin S.S., Liu C., Chang E.Y., et al. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts. J Hand Surg Am 2004, 29:809-814.
46. Forsman M., Paakkonen V., Tjaderhane L., et al. The expression of myoglobin and ROR2 protein in Dupuytren's disease. J Surg Res 2008, 146:271-275.
47. Baird K.S., Crossan J.F., Ralston S.H. Abnormal growth factor and cytokine expression in Dupuytren's contracture. J Clin Pathol 1993, 46:425-428.